Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | GLS | O94925 | 5/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 8/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10403061 | 0.88 | KDM4E (0.40) | KDM4EGLSALOX5APEX1ALDH1A1 | |
| SCHEMBL10403063 | 0.80 | KDM4E (0.40) | KDM4EGLSALOX5APEX1ALDH1A1 | |
| SCHEMBL10403230 | 0.76 | GAA (0.54) | ALDH1A1POLB | |
| SCHEMBL10404479 | 0.76 | APEX1 (0.37) | KDM4EGLSAPEX1ALDH1A1TDP1 | |
| SCHEMBL10404478 | 0.76 | KDM4E (0.34) | KDM4EGLSAPEX1ALDH1A1POLB | |
| SCHEMBL10403434 | 0.72 | KMT2A (0.37) | KDM4EALDH1A1 | |
| SCHEMBL27264852 | 0.71 | KDM4E (0.38) | KDM4EALDH1A1 | |
| SCHEMBL10403614 | 0.69 | ALDH1A1 (0.32) | KDM4EAPEX1ALDH1A1 | |
| SCHEMBL10402166 | 0.67 | ALOX5 (0.39) | ALOX5ALDH1A1POLB | |
| SCHEMBL10767752 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4914206-A | ANTIBIOTICS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-04-03 | — | — | US | disclosed |
| EP-0226896-A2 | Lankacidin derivatives and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1987-07-01 | — | — | EP | disclosed |